Clinical resistance encountered in the respiratory surveillance program (RESP) study: a review of the implications for the treatment of community-acquired respiratory tract infections-Reference-Cited by-同舟云学术

Clinical resistance encountered in the respiratory surveillance program (RESP) study: a review of the implications for the treatment of community-acquired respiratory tract infections

Published:2001-12 Issue:9 Volume:111 Page:30-35
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Ehrhardt Anton F,Russo René

Publisher

Elsevier BV

Subject

General Medicine

Reference62 articles.

1. Practice guidelines for the management of community-acquired pneumonia in adults;Bartlett;Clin Infect Dis.,2000

2. Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States;Burwen;J Infect Dis.,1994

3. Trends in antibiotic utilization and bacterial resistance. Report of the National Nosocomial Resistance Surveillance Group;Ballow;Diagn Microbiol Infect Dis.,1992

4. National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae;Doern;Antimicrob Agents Chemother.,1988

5. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995;Doern;Antimicrob Agents Chemother.,1996

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What is the Role of Antimicrobial Stewardship in Improving Outcomes of Patients with CAP?;Infectious Disease Clinics of North America;2013-03

2. Bacteria;Molecular Pathology Library;2008

3. Acute Exacerbations of Chronic Bronchitis;Wiley Handbook of Current and Emerging Drug Therapies;2006-09-15

4. Tigecycline;Journal of Antimicrobial Chemotherapy;2005-07-22

5. In vitro activity of gemifloxacin and contemporary oral antimicrobial agents against 27,247 Gram-positive and Gram-negative aerobic isolates: a global surveillance study;International Journal of Antimicrobial Agents;2004-02